HANPOONG PHARM CO.,LTD. · 99-39 · KOREA (THE REPUBLIC OF)
For HANPOONG PHARM CO.,LTD. · 99-39 · KOREA (THE REPUBLIC OF), import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is KOREA (THE REPUBLIC OF); product code is 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human); date published is 08/14/2017; address is 11 Guretdeul 3-Gil Deokjin-Gu , Jeonju, KOREA (THE REPUBLIC OF), verified against its source on 2026-09-16.
- Firm
- HANPOONG PHARM CO.,LTD. verified
- Import alert
- 99-39
- Import alert name
- Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- Country
- KOREA (THE REPUBLIC OF) verified
- Address
- 11 Guretdeul 3-Gil Deokjin-Gu , Jeonju, KOREA (THE REPUBLIC OF) verified
- Date published
- 08/14/2017 verified
- Product code
- 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) verified
- FDA notes
- DaChaiHe Tang (also known as DaChaiHu Tang); Section 403(s)(2)(B) of the Act in that the label of the dietary supplement fails to identify the product by using the term "dietary supplement" in accordance with 21 CFR 101.3(g). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the product does not comply with 21 CFR 101.36. Section 403(i)(2) of the Act [21 U.S.C.§343(i)(2)], in that each ingredient is not declared by its common or usual name in accordance with 21 CFR 101.4 Section 403(s)(2)(A)(ii)(I) of the Act in that it fails to include the quantitative amount by weight per serving size of all the dietary ingredients as required by 21CFR 101.36. Section 403(s)(2)(C) of the Act because the label fails to identify the part of the plant from which all the botanical dietary ingredients in the product are derived as required by 21CFR 101.4(h)(1). Section 403(q) of the FD&C Act in that the required nutrition information is not in the appropriate format in accordance with 21 CFR 101.9. Section 403(f) of the Act [21 U.S.C. 343(f)] in that the product label contains information in two languages but does not repeat all the required label information in both languages as required by 21CFR 101.15(c). Section 403(e)(2) of the Act because the label fails to declare the net quantity of contents on the principal display panel as required by 21 CFR 101.7. verified
What the source says
HANPOONG PHARM CO.,LTD. Date Published : 08/14/2017 11 Guretdeul 3-Gil Deokjin-Gu , Jeonju, KOREA (THE REPUBLIC OF) 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) Date Published: 08/14/2017 Notes: DaChaiHe Tang (also known as DaChaiHu Tang); Section 403(s)(2)(B) of the Act in that the label of the dietary supplement fails to identify the product by using the term "dietary supplement" in accordance with 21 CFR 101.3(g). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the product does not comply with 21 CFR 101.36. Section 403(i)(2) of the Act [21 U.S.C.§343(i)(2)], in that each ingredient is not declared by its common or usual name in accordance with 21 CFR 101.4 Section 403(s)(2)(A)(ii)(I) of the Act in that it fails to include the quantitative amount by weight per serving size of all the dietary ingredients as required by 21CFR 101.36. Section 403(s)(2)(C) of the Act because the label fails to identify the part of the plant from which all the botanical dietary ingredients in the product are derived as required by 21CFR 101.4(h)(1). Section 403(q) of the FD&C Act in that the required nutrition information is not in the appropriate format in accordance with 21 CFR 101.9. Section 403(f) of the Act [21 U.S.C. 343(f)] in that the product label contains information in two languages but does not repeat all the required label information in both languages as required by 21CFR 101.15(c). Section 403(e)(2) of the Act because the label fails to declare the net quantity of contents on the principal display panel as required by 21 CFR 101.7.
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_1144.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.